Assembly Biosciences, Inc. 8-K Report: Key Insights & Updates for Investors

Based on the provided XML snippet from the financial report, here are the key insights and information extracted:

Entity Information:

Company Name: Assembly Biosciences, Inc.
CIK Number: 0001426800
State of Incorporation: Delaware (DE)
SEC Central Index Key (CIK): 0001426800
IRS Employer Identification Number (EIN): 20-8729264
Headquarters Address: Two Tower Place, 7th Floor, South San Francisco, CA 94080
Phone Number: (833) 509-4583

Filing Information:

Filing Type: 8-K (current report)
Filing Date: December 30, 2024
Stock Ticker Symbol: ASMB (traded on NASDAQ)
Common Stock Par Value: $0.001

Reporting Period:

Start Date: December 30, 2024
End Date: December 30, 2024

XBRL Information:

The document is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting.

Insights:

The filing date coincides with the end date of the reporting period, indicating that the report likely contains information relevant to a specific event or condition that occurred on that date.
The use of Form 8-K suggests that Assembly Biosciences may be disclosing significant events or changes that shareholders need to be aware of, which could impact stock performance.
The company is publicly traded, and as such, it is subject to SEC regulations and requirements for timely disclosures to investors.

This information can be vital for investors, analysts, or stakeholders looking to understand the current status and recent activities of Assembly Biosciences, Inc.